Rankings
▼
Calendar
PASG FY 2018 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$28M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-10.60
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$21M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$33M
Total Liabilities
$46M
Stockholders' Equity
-$12M
Cash & Equivalents
$25M
← Q4 2018
All Quarters
